Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Amneal vs DAVA Methotrexate in Psoriasis or RA
NCT02940561Phase 1Unknown
- Sponsor
- Amneal Pharmaceuticals, Inc.
- Start
- Aug 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methotrexate in psoriasis and rheumatoid arthritis (RA) (2 arms), sponsored by Amneal Pharmaceuticals, Inc. Primary endpoints: Area Under the Curve (AUC0-12) at Day 1 and Maximum Plasma Concentration at Day 1. Status: unknown.
02
Drugs
methotrexate
03
Conditions
psoriasisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02940561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940561.